Free Trial

Colgate-Palmolive (CL) Stock Forecast & Price Target

Colgate-Palmolive logo
$88.04 +0.83 (+0.95%)
As of 02:24 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Colgate-Palmolive - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Sell
0
Hold
7
Buy
12

Based on 19 Wall Street analysts who have issued ratings for Colgate-Palmolive in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 19 analysts, 7 have given a hold rating, and 12 have given a buy rating for CL.

Consensus Price Target

$98.65
12.05% Upside
According to the 19 analysts' twelve-month price targets for Colgate-Palmolive, the average price target is $98.65. The highest price target for CL is $110.00, while the lowest price target for CL is $87.00. The average price target represents a forecasted upside of 12.05% from the current price of $88.04.
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
Get the Latest News and Ratings for CL and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Colgate-Palmolive and its competitors.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CL Analyst Ratings Over Time

TypeCurrent Forecast
10/8/25 to 10/8/26
1 Month Ago
9/8/25 to 9/8/26
3 Months Ago
7/10/25 to 7/10/26
1 Year Ago
10/8/24 to 10/8/25
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
12 Buy rating(s)
12 Buy rating(s)
12 Buy rating(s)
8 Buy rating(s)
Hold
7 Hold rating(s)
7 Hold rating(s)
7 Hold rating(s)
5 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$98.65$99.00$96.29$94.31
Forecasted Upside12.05% Upside12.03% Upside4.32% Upside20.97% Upside
Consensus RatingModerate BuyModerate BuyModerate BuyModerate Buy

CL Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

CL Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Colgate-Palmolive Stock vs. The Competition

TypeColgate-PalmoliveConsumer Staples CompaniesBroader Market
Consensus Rating Score
2.63
2.22
2.52
Consensus RatingModerate BuyHoldModerate Buy
Predicted Upside11.80% Upside166.08% Upside19.86% Upside
News Sentiment Rating
Positive News

See Recent CL News
Neutral News
Neutral News
Report Date
0 Results
DateBrokerageAnalystActionRatingPrice TargetReport Date
Upside/Downside
Details
10/5/2026
Chris Carey
Chris Carey
3 of 5 stars
Lower TargetEqual Weight$95.00 ➝ $90.00+5.00%
10/2/2026
Weiss Ratings logo
Weiss Ratings
3 of 5 stars
 DowngradeBuy (B-) ➝ Hold (C+)
9/21/2026
Piper Sandler logo
Piper Sandler
2 of 5 stars
Michael Lavery
Michael Lavery
2 of 5 stars
Lower TargetOverweight$98.00 ➝ $95.00+8.57%
9/8/2026Reiterated RatingOutperform$104.00+17.54%
8/13/2026Reiterated RatingMarket Perform
8/3/2026Reiterated RatingBuy$101.00+10.42%
8/3/2026Reiterated RatingOverweight$104.00+12.06%
8/3/2026Boost TargetBuy$106.00 ➝ $109.00+17.45%
8/3/2026Boost TargetHold$85.00 ➝ $90.00-3.03%
8/3/2026 Reiterated RatingHold
8/3/2026Lower TargetOverweight$104.00 ➝ $103.00+12.67%
7/21/2026Boost TargetEqual Weight$80.00 ➝ $87.00-5.36%
7/14/2026Boost TargetBuy$105.00 ➝ $110.00+18.09%
5/1/2026 Reiterated RatingBuy
4/21/2026Set TargetNeutral ➝ Buy$93.00 ➝ $100.00+19.78%
4/10/2026Lower TargetBuy$105.00 ➝ $102.00+18.58%
2/2/2026Boost TargetOutperform$94.00 ➝ $100.00+10.76%
12/11/2025Reiterated RatingBuy ➝ Hold
10/20/2025Lower TargetOutperform$105.00 ➝ $95.00+20.01%
2/3/2025Lower TargetHold$95.00 ➝ $93.00+7.86%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 02:13 PM ET.


Should I Buy Colgate-Palmolive Stock? CL Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Sunday, October 4, 2026. Please send any questions or comments about these Colgate-Palmolive pros and cons to contact@marketbeat.com.

Colgate-Palmolive
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Colgate-Palmolive:

  • Colgate-Palmolive is currently trading at $84.22, which is significantly below the consensus price target of $98.94 set by nineteen research firms, suggesting substantial upside potential for investors who believe the market is undervaluing the company's long-term stability and growth prospects.
  • The company recently reported strong financial performance in its latest quarter, beating consensus estimates with earnings per share of $0.99 compared to the expected $0.95, while also achieving revenue of $5.36 billion that matched analyst expectations and grew 4.9% year-over-year, demonstrating consistent operational execution.
  • As a Dividend King that has paid dividends without interruption since 1895, Colgate-Palmolive offers a reliable income stream with a current yield of 2.52%, making it an attractive option for income-focused investors seeking stability in a volatile market environment.
  • Institutional investors are showing renewed confidence in the stock, with major firms like Confluence Investment Management LLC increasing their stake by 20.8% in the third quarter and Envestnet Asset Management Inc. boosting its position by 266.5% in the second quarter, indicating strong professional backing for the company's future.
  • The company is actively pursuing strategic growth through innovation and premiumization, such as the recent launch of Tom's of Maine Hydroxyapatite Toothpaste to meet rising consumer demand for natural oral care, which positions Colgate-Palmolive to capture market share in high-growth segments.

Colgate-Palmolive
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Colgate-Palmolive for these reasons:

  • Colgate-Palmolive is exploring the potential sale of certain mass-market personal care brands, including Softsoap, Irish Spring, and Speed Stick, which could generate over $1 billion but may signal a retreat from core business areas and create uncertainty about the company's long-term brand portfolio strategy.
  • Insiders have been selling significant portions of their holdings recently, with CEO Noel R. Wallace selling 161,021 shares and COO Panagiotis Tsourapas selling 10,000 shares in August 2026, which may indicate a lack of confidence in the stock's near-term performance or a desire to diversify personal wealth.
  • The company's valuation remains premium with a price-to-earnings ratio of 33.42, which is high for a consumer staples company and leaves little room for error if growth slows, particularly given concerns about a shrinking North American business and the need for continued international expansion to justify the price.
  • Colgate-Palmolive has a high dividend payout ratio of 84.13%, meaning the company is distributing a large portion of its earnings to shareholders, which could limit its ability to reinvest in growth initiatives or weather economic downturns without cutting dividends, a risk that is heightened by its premium valuation.
  • The stock has underperformed relative to its 52-week high of $99.33, currently trading at $84.22, and faces competitive pressures in the consumer products sector that could erode margins and market share if the company fails to maintain its innovation and premiumization momentum.

CL Forecast - Frequently Asked Questions

According to the research reports of 19 Wall Street equities research analysts, the average twelve-month stock price forecast for Colgate-Palmolive is $98.65, with a high forecast of $110.00 and a low forecast of $87.00.

19 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Colgate-Palmolive in the last year. There are currently 7 hold ratings and 12 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" CL shares.

According to analysts, Colgate-Palmolive's stock has a predicted upside of 12.05% based on their 12-month stock forecasts.

Over the previous 90 days, Colgate-Palmolive's stock had 1 upgrade and 1 downgrade by analysts.

Analysts like Colgate-Palmolive more than other "consumer staples" companies. The consensus rating for Colgate-Palmolive is Moderate Buy while the average consensus rating for "consumer staples" companies is Hold. Learn more on how CL compares to other companies.


MarketBeat monitors more than a dozen sources for Colgate-Palmolive analyst ratings, with the most recent rating issued on 10/5/2026.
From Our Partners